Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial

被引:0
作者
T J Murtola
T L J Tammela
L Määttänen
M Ala-opas
U H Stenman
A Auvinen
机构
[1] School of Public Health,Department of Surgery
[2] University of Tampere,Department of Urology
[3] Central Finland Central Hospital,Department of Urology
[4] Tampere University Hospital,Department of Clinical Chemistry
[5] Medical School,undefined
[6] University of Tampere,undefined
[7] The Finnish Cancer Registry,undefined
[8] Helsinki University Hospital,undefined
[9] University of Helsinki,undefined
来源
British Journal of Cancer | 2009年 / 101卷
关键词
alpha-blockers; benign prostatic hyperplasia; finasteride; epidemiology; prostatic neoplasms; screening;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:843 / 848
页数:5
相关论文
共 112 条
  • [1] Benning CM(2002)Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action Cancer Res 62 597-602
  • [2] Kyprianou N(2003)Epidemiology of prostate cancer Urology 62 3-12
  • [3] Crawford ED(2005)Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial J Urol 174 877-881
  • [4] Etzioni RD(2007)Effect of J Urol 178 2176-2180
  • [5] Howlader N(2002)1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study J Urol 168 1985-1988
  • [6] Shaw PA(2002)Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk Int J Urol 9 607-612
  • [7] Ankerst DP(2000)Evidence-based meta-analysis of pharmacotherapy for benign prostatic hypertrophy Cancer Res 60 4550-4555
  • [8] Penson DF(2007)Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis J Natl Cancer Inst 99 1375-1383
  • [9] Goodman PJ(1999)Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial Br J Cancer 79 1210-1214
  • [10] Thompson IM(2006)European randomized study of screening for prostate cancer: first-year results of the Finnish trial Nat Clin Pract Urol 3 495-503